ARTLVSCTSO• 28 Days (Normalized)
ARTL vs CTSO (Artelo Biosciences Inc. vs Cytosorbents Corporation)
Showing Closing Date Range from Sep 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-30.37%
Artelo Biosciences Inc.
Normalized Baseline0.00%
CTSO Performance $4.91
+%
Cytosorbents Corporation
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
-30.37 pts
CTSO outperforming by 30.37 percentage points
ARTLCTSO
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL CTSO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(17 dates)
| Date | ARTL Price | ARTL Gain (%) | CTSO Price | CTSO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -30.37% | $- | - | |
| Sep 24, 2026 | $5.17 | -20.71% | $- | - | |
| Sep 23, 2026 | $7.31 | +12.12% | $4.91 | +1178.65% | -1166.53% |
| Sep 22, 2026 | $4.15 | -36.35% | $- | - | |
| Sep 21, 2026 | $4.10 | -37.12% | $5.51 | +1334.90% | -1372.02% |
| Sep 18, 2026 | $3.94 | -39.57% | $5.75 | +1397.40% | -1436.97% |
| Sep 17, 2026 | $3.97 | -39.11% | $5.76 | +1400.00% | -1439.11% |
| Sep 16, 2026 | $3.75 | -42.48% | $5.73 | +1392.19% | -1434.67% |
| Sep 15, 2026 | $5.34 | -18.10% | $6.06 | +1478.12% | -1496.22% |
| Sep 14, 2026 | $4.87 | -25.31% | $6.07 | +1480.73% | -1506.04% |
| Sep 11, 2026 | $5.43 | -16.72% | $6.41 | +1569.27% | -1585.99% |
| Sep 10, 2026 | $5.63 | -13.65% | $6.37 | +1558.85% | -1572.50% |
| Sep 09, 2026 | $5.98 | -8.28% | $6.33 | +1548.44% | -1556.72% |
| Sep 08, 2026 | $6.19 | -5.06% | $- | - | |
| Sep 04, 2026 | $6.04 | -7.36% | $0.35 | -8.85% | +1.49% |
Page 1 of 2